Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.150
+0.010 (0.88%)
At close: May 29, 2026, 4:00 PM EDT
1.120
-0.030 (-2.61%)
Pre-market: Jun 1, 2026, 8:22 AM EDT
Standard BioTools Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Standard BioTools stock has a consensus rating of "Buy" and an average price target of $1.55. The average 1-year stock price forecast is 34.78% higher than the current stock price, while the lowest is $1.35 (+17.39%) and the highest is $1.75 (+52.17%).
Price Target: $1.55 (+34.78%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Standard BioTools stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $1.35 | Hold | Maintains | $1.35 | +17.39% | May 6, 2026 |
| KeyBanc | KeyBanc | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Feb 25, 2026 |
Financial Forecast
Revenue This Year
83.33M
from 85.33M
Decreased by -2.35%
Revenue Next Year
84.94M
from 83.33M
Increased by 1.94%
EPS This Year
-0.16
from -0.20
EPS Next Year
-0.16
from -0.16
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 86.6M | 90.4M | |
| Avg | 83.3M | 84.9M | |
| Low | 80.9M | 80.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5% | 8.5% | |
| Avg | -2.4% | 1.9% | |
| Low | -5.3% | -3.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.17 | -0.17 | |
| Avg | -0.16 | -0.16 | |
| Low | -0.16 | -0.16 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.